IP Library › Assignment 022343/0275
Patent Assignment
Reel/Frame 022343/0275

Assignment of Assignor's Interest

Recorded: 2009-03-04 Pages: 6
Assignor
PDL BIOPHARMA, INC.
Executed: 2009-02-09
Assignee
FACET BIOTECH CORPORATION
1400 SEAPORT BLVD., REDWOOD CITY, CALIFORNIA, 94063
Covered Properties (3)
Anti-CCR5 Antibody
Patent: 7,122,185 →
Application: 10/371,483 →
Publication: US 2003/0228306
Anti-CCR5 Antibody
Patent: 7,851,600 →
Application: 11/581,944 →
Publication: US 2008/0107595
Anti-CCR5 Antibody
Patent: 7,666,419 →
Application: 11/581,945 →
Publication: US 2007/0031408
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 18, 2003
From: TSURUSHITA, NAOYA; HINTON, PAUL R.; VASQUEZ, MAXIMILLANO
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014392/0780 →
Assignment of Assignor's Interest Aug 18, 2003
From: OLSON, WILLIAM C.; MADDON, PAUL J.
To: PROGENICS PHARMACEUTICALS, INC.
Reel/Frame 014393/0471 →
Change of Name May 22, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017655/0436 →
Change of Name Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Assignment of Assignor's Interest Jan 15, 2013
From: PROGENICS PHARMACEUTICALS, INC.
To: CYTODYN, INC.
Reel/Frame 029633/0837 →
Change of Name Feb 19, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 029834/0215 →